Radiation therapy after radical surgery in prostate cancer

FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of LARC prior to low anterior resection with TME

Primary mediastinal B-cell lymphoma: Radiotherapy superfluous post-chemoimmunotherapy

Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer

Optimising cervical cancer care in Nigeria

Management of prostate cancer in Africa: Looking to the future

Choosing cancer medicines wisely in Africa

The HypoAfrica study and AC3T research partnerships at NLCC

War in Ukraine: The impacts and challenges the Polish cancer care system has faced

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer